Erkka Valovirta

Summary

Publications

  1. doi request reprint Parental attitudes toward new dosage forms of desloratadine in an online survey: results from four European countries
    Erkka Valovirta
    Turku Allergy Center, Turku, Finland
    Curr Med Res Opin 25:2061-7. 2009
  2. pmc EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy
    Moises A Calderon
    Section of Allergy and Clinical Immunology, Imperial College, National Heart and Lung Institute, Dovehouse Street, London, SW3 6LY, UK
    Clin Transl Allergy 2:20. 2012
  3. doi request reprint Intermittent or daily montelukast versus placebo for episodic asthma in children
    Erkka Valovirta
    Allergy Clinic, Suomen Terveystalo AllergyClinic, Turku, Finland
    Ann Allergy Asthma Immunol 106:518-26. 2011
  4. doi request reprint Effect of AIT in children including potential to prevent the development of asthma
    E Valovirta
    Suomen Terveystalo Allergy Turku Allergy Centre, Turku, Finland
    Allergy 66:53-4. 2011
  5. doi request reprint Design and recruitment for the GAP trial, investigating the preventive effect on asthma development of an SQ-standardized grass allergy immunotherapy tablet in children with grass pollen-induced allergic rhinoconjunctivitis
    Erkka Valovirta
    Suomen Terveystalo Allergy Clinic, Turku, Finland
    Clin Ther 33:1537-46. 2011
  6. doi request reprint Clinical outcome and IL-17, IL-23, IL-27 and FOXP3 expression in peripheral blood mononuclear cells of pollen-allergic children during sublingual immunotherapy
    Kaisa Nieminen
    Department of Pulmonary Diseases and Clinical Allergology, University of Turku, Turku, Finland
    Pediatr Allergy Immunol 21:e174-84. 2010
  7. ncbi request reprint Non-injection routes for immunotherapy of allergic diseases
    Erkka Valovirta
    Turku Allergy Center, Turku, Finland
    Clin Allergy Immunol 18:607-23. 2004
  8. doi request reprint The voice of the patients: allergic rhinitis is not a trivial disease
    Erkka Valovirta
    Turku Allergy Center, Turku, Finland
    Curr Opin Allergy Clin Immunol 8:1-9. 2008

Collaborators

  • Walter G Canonica
  • Jacques de Blic
  • Giovanni Passalacqua
  • Albrecht Bufe
  • George Philip
  • Colin F Robertson
  • Graham Roberts
  • Eva Maria Varga
  • Moises A Calderon
  • Kaisa Nieminen
  • Ludger Klimek
  • Jean Bousquet
  • Victoria Cardona
  • Marianne van Hage
  • Roy Gerth van Wijk
  • Carmen Moreno
  • Antonio Nieto
  • Nikolaos Papadopoulos
  • Jocelyne Just
  • Cezmi Akdis
  • Marek Jutel
  • Jörg Kleine-Tebbe
  • Johannes C Virchow
  • Hans J Malling
  • Gabriela Senti
  • Giovanni Pajno
  • Pascal Demoly
  • Claus Bachert
  • Antonella Muraro
  • Lars Jacobsen
  • Oliver Pfaar
  • Carmen Vidal
  • Ulrich Wahn
  • Montserrat Fernandez-Rivas
  • Stephen R Durham
  • Anthony Frew
  • Peter Eng
  • Jan Lotvall
  • Rudolph Valenta
  • Beatrice Bilo
  • Aziz Sheikh
  • Bodo Niggemann
  • Gianenrico Senna
  • Emilio Alvarez-Cuesta
  • Alain Didier
  • Ronald Dahl
  • Ralph Mosges
  • Glenis Scadding
  • Barbara Bohle
  • Sabina Rak
  • Johannes Savolainen

Detail Information

Publications8

  1. doi request reprint Parental attitudes toward new dosage forms of desloratadine in an online survey: results from four European countries
    Erkka Valovirta
    Turku Allergy Center, Turku, Finland
    Curr Med Res Opin 25:2061-7. 2009
    ..These excipients, however, are associated with dental caries, gastrointestinal intolerance, and dermatologic reactions...
  2. pmc EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy
    Moises A Calderon
    Section of Allergy and Clinical Immunology, Imperial College, National Heart and Lung Institute, Dovehouse Street, London, SW3 6LY, UK
    Clin Transl Allergy 2:20. 2012
    ....
  3. doi request reprint Intermittent or daily montelukast versus placebo for episodic asthma in children
    Erkka Valovirta
    Allergy Clinic, Suomen Terveystalo AllergyClinic, Turku, Finland
    Ann Allergy Asthma Immunol 106:518-26. 2011
    ..No standard, optimal treatment exists for severe intermittent (ie, episodic) asthma in children. However, evidence suggests that both daily and episode-driven montelukast are effective for this phenotype...
  4. doi request reprint Effect of AIT in children including potential to prevent the development of asthma
    E Valovirta
    Suomen Terveystalo Allergy Turku Allergy Centre, Turku, Finland
    Allergy 66:53-4. 2011
    ..In a few years, the results will show if grass AIT with Grazax® can prevent the development of asthma in children suffering from allergic rhinoconjunctivitis...
  5. doi request reprint Design and recruitment for the GAP trial, investigating the preventive effect on asthma development of an SQ-standardized grass allergy immunotherapy tablet in children with grass pollen-induced allergic rhinoconjunctivitis
    Erkka Valovirta
    Suomen Terveystalo Allergy Clinic, Turku, Finland
    Clin Ther 33:1537-46. 2011
    ..No regulatory guidance exists in this area, and, to our knowledge, no clinical investigations meeting modern regulatory standards have been published...
  6. doi request reprint Clinical outcome and IL-17, IL-23, IL-27 and FOXP3 expression in peripheral blood mononuclear cells of pollen-allergic children during sublingual immunotherapy
    Kaisa Nieminen
    Department of Pulmonary Diseases and Clinical Allergology, University of Turku, Turku, Finland
    Pediatr Allergy Immunol 21:e174-84. 2010
    ..Increased allergen-induced IL-17 responses during SLIT are associated with elevated SMS. Increased tolerogenic, allergen-specific Treg responses are also observed in children during SLIT...
  7. ncbi request reprint Non-injection routes for immunotherapy of allergic diseases
    Erkka Valovirta
    Turku Allergy Center, Turku, Finland
    Clin Allergy Immunol 18:607-23. 2004
  8. doi request reprint The voice of the patients: allergic rhinitis is not a trivial disease
    Erkka Valovirta
    Turku Allergy Center, Turku, Finland
    Curr Opin Allergy Clin Immunol 8:1-9. 2008
    ..Background information on allergic rhinitis, severity of allergic rhinitis symptoms and their impact on lives, nonmedical measures for relieving of symptoms, types of medications, and concomitant conditions were evaluated...